Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis – a multicentre study

Hegen, Harald;Berek, Klaus;Cavalla, Paola;Christiansen, Mikael;Deisenhammer, Florian;et.al.
(2023) Frontiers in Immunology — Vol. 14, p. 1327947 [1-6] (2023)

Files

fimmu-14-1327947.pdf
  • Open Access
  • Adobe PDF
  • 1.12 MB

Details

Authors
  • Hegen, Harald
    Author
  • Berek, Klaus
    Author
  • Cavalla, Paola
    Author
  • Christiansen, Mikael
    Author
  • Author
  • Deisenhammer, Florian
    Author
Show more
Abstract
(en) BACKGROUND: Kappa free light chains (κ-FLC) in the cerebrospinal fluid (CSF) are an emerging biomarker in multiple sclerosis (MS). OBJECTIVE: To investigate whether κ-FLC index has similar diagnostic value in patients with primary progressive multiple sclerosis (PPMS) compared to oligoclonal bands (OCB). METHODS: Patients with PPMS were recruited through 11 MS centres across 7 countries. κ-FLC were measured by immunonephelometry/-turbidimetry. OCB were determined by isoelectric focusing and immunofixation. RESULTS: A total of 174 patients (mean age of 52±11 years, 51% males) were included. κ-FLC index using a cut-off of 6.1 was positive in 161 (93%) and OCB in 153 (88%) patients. CONCLUSION: κ-FLC index shows similar diagnostic sensitivity than OCB in PPMS.
Affiliations

Citations

Hegen, H., Berek, K., Cavalla, P., Christiansen, M., Emeršič, A., Di Filippo, M., Gaetani, L., Hassler, M., Leurs, C., Milosavljevic, D., Van Pesch, V., Petersen, T., Presslauer, S., Rosenstein, I., Rot, U., Schnabl, C., Teunissen, C., Vecchio, D., Vercellino, M., & Deisenhammer, F. (2023). Diagnostic value of kappa free light chain index in patients with primary progressive multiple sclerosis – a multicentre study. Frontiers in Immunology, 14, 1327947 [1-6]. https://doi.org/10.3389/fimmu.2023.1327947 (Original work published 2023)